Cell mediated immunity (CMI) and post transplant viral infections - Role of a functional immune assay to titrate immunosuppression

被引：28
作者：
Gautam, A.
Fischer, S. A.
Yango, A. F.
Gohh, R. Y.
Morrissey, P. E.
Monaco, A. P.
机构：
[1] Rhode Isl Hosp, Div Organ Transplantat, Providence, RI 02903 USA
[2] Brown Med Sch, Dept Surg, Providence, RI USA
[3] Brown Med Sch, Div Nephrol, Dept Med, Providence, RI USA
[4] Brown Med Sch, Div Infect Dis, Dept Med, Providence, RI USA
来源：
INTERNATIONAL IMMUNOPHARMACOLOGY | 2006年 / 6卷 / 13-14期
关键词：
cell mediated immunity; immunological monitoring; immunosuppression;
D O I：
10.1016/j.intimp.2006.09.023
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Cell mediated immunity (CMI) was assessed by the ImmuKnow assay in 12 patients after kidney transplantation, who presented with viral infection. Treatment included lowering of immunosuppression in all cases and antiviral treatment if indicated. The assay was repeated during the follow up. The ImmuKnow assay at time of presentation of viral infections was 56.8 +/- 58.2 (range 3-178; median 22) ATP ng/ml. With the clearance of vital infection and lowering of immunosuppression, the assay showed an increase in the level of CMI at 194.5 +/- 118.9 (range 53-409; median 150) ATP ng/ml. There was viral clearance or stabilization in all cases and there was no incidence of allograft rejection. The ImmuKnow assay of CMI can be used to titrate initial immunosuppression reduction and its subsequent increase, in patients with viral infection after transplantation. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码：2023 / 2030
页数：8
相关论文
共 8 条
[1]   INCREASED RISK OF PNEUMOCOCCAL INFECTIONS IN CARDIAC TRANSPLANT RECIPIENTS [J].
AMBER, IJ ;
GILBERT, EM ;
SCHIFFMAN, G ;
JACOBSON, JA .
TRANSPLANTATION, 1990, 49 (01) :122-125
[2]   Immunogenicity of pneumococcal vaccine in heart transplant recipients [J].
Blumberg, EA ;
Brozena, SC ;
Stutman, P ;
Wood, D ;
Phan, HM ;
Musher, DM .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (02) :307-310
[3]   Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation [J].
Dengler, TJ ;
Strnad, N ;
Buhring, I ;
Zimmermann, R ;
Girgsdies, O ;
Kubler, WE ;
Zielen, S .
TRANSPLANTATION, 1998, 66 (10) :1340-1347
[4]   Vaccinations for adult solid-organ transplant recipients: Current recommendations and protocols [J].
Duchini, A ;
Goss, JA ;
Karpen, S ;
Pockros, PJ .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (03) :357-+
[5]   Effect of immunosuppression after cardiac transplantation in early childhood on antibody response to polysaccharide antigen [J].
Gennery, AR ;
Cant, AJ ;
Spickett, GP ;
Walshaw, D ;
Hunter, S ;
Hasan, A ;
Hamilton, JRL ;
Dark, J .
LANCET, 1998, 351 (9118) :1778-1781
[6]   Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation [J].
Sarmiento, E ;
Rodríguez-Molina, J ;
Muñoz, P ;
Fernández-Yánez, J ;
Palomo, J ;
Fogueda, M ;
Fernández-Cruz, E ;
Bouza, E ;
Carbone, J .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) :4046-4049
[7]   Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults [J].
Schauer, U ;
Stemberg, F ;
Rieger, CHL ;
Büttner, W ;
Borte, M ;
Schubert, S ;
Möllers, H ;
Riedel, F ;
Herz, U ;
Renz, H ;
Herzog, W .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (02) :202-207
[8]   Practice parameters for the diagnosis and management of immunodeficiency [J].
Shearer, WT ;
Buckley, RH ;
Engler, RJM ;
Finn, AF ;
Fleisher, TA ;
Freeman, TM ;
Herrod, HG ;
Levinson, AI ;
Lopez, M ;
Rich, RR ;
Rosenfeld, SI ;
Rosenwasser, LJ .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1996, 76 (03) :282-294
1